Parental attitudes toward multiple poliovirus injections following a provider recommendation.
OBJECTIVE
Changes to the polio vaccination schedule, first to a sequential inactivated poliovirus/oral poliovirus (IPV/OPV) schedule in 1996 and most recently to an all-IPV schedule, require infants to receive additional injections. Some surveys show parental hesitation concerning extra injections, whereas others show that parents prefer multiple simultaneous injections over extra immunization visits. This study describes parental behavior and attitudes about the poliovirus vaccine recommendations and additional injections at the 2- and 4-month immunization visits.


METHODS
Beginning July 1, 1996, providers in eight public health clinics in Cobb and Douglas Counties, Georgia, informed parents of polio vaccination options and recommended the IPV/OPV sequential schedule. A cross-sectional clinic exit survey was conducted from July 15, 1996, to January 31, 1997, with parents whose infants (younger than 6 months) were eligible for a first poliovirus vaccination.


RESULTS
Of approximately 405 eligible infants, parents of 293 infants were approached for an interview, and 227 agreed to participate. Of those 227 participants, 210 (92%) parents chose IPV for their infant and 17 (8%) chose OPV. Of greatest concern to most parents was vaccine-associated paralytic polio (VAPP) (155, or 68.3%); the next greatest concern was an extra injection (22, or 9.7%). These parental concerns were unrelated to the number of injections the infant actually received.


CONCLUSIONS
After receiving information on polio vaccination options and a provider recommendation, parents overwhelmingly chose IPV over OPV. Concern about VAPP was more common than objection to an extra injection. The additional injection that results from using IPV for an infant's first poliovirus vaccination appears to be acceptable to most parents.
Kolasa
M S
MS
National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS E-52, Atlanta, GA 30333, USA. mkolasa@cdc.gov
Bisgard
K M
KM
Prevots
D R
DR
Desai
S N
SN
Dibling
K
K
D000284:Administration, Oral; D000328:Adult; D003151:Community Health Centers; D005845:Georgia; D019538:Health Care Surveys; D006801:Humans; D007115:Immunization Schedule; D007267:Injections / Q000706:statistics & numerical data; D010290:Parents / Q000523:psychology*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D011051:Poliomyelitis / Q000139:chemically induced / Q000635:transmission; D023321:Poliovirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D015164:Vaccines, Inactivated / Q000008:administration & dosage
D023321:Poliovirus Vaccines; D015164:Vaccines, Inactivated